日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Making sense of PROM outcomes: a mixed method study to optimize graphical visualization formats for children

理解患者报告结局指标（PROM）结果：一项旨在优化儿童图形可视化格式的混合方法研究

期刊:Quality of Life Research
影响因子:2.7
doi:10.1007/s11136-026-04172-5
Limmen, Selina; van Muilekom, Maud M; Korteling, Dorinde L; Teela, Lorynn; Boers, Maarten; Terwee, Caroline B; van Oers, Hedy A; Haverman, Lotte; Luijten, Michiel A J
发表日期：2026
文献求助 收藏

What Matters Most? Developing a Core Patient Reported Outcome Set for Individuals With Genetic Intellectual Disabilities: An International Delphi Study

什么最重要？为遗传性智力障碍患者制定核心患者报告结局指标集：一项国际德尔菲研究

期刊:Journal of Intellectual Disability Research
影响因子:
doi:10.1111/jir.70081
van Silfhout, Nadia Y; van Muilekom, Maud M; Menke, Leonie A; van Karnebeek, Clara D; Haverman, Lotte; van Eeghen, Agnies M
发表日期：2026
文献求助 收藏

Changes in the quality of life of adults with sickle cell disease following allogeneic stem cell transplantation: A mixed-methods, prospective cohort study

异基因造血干细胞移植后镰状细胞病成人患者生活质量的变化：一项混合方法前瞻性队列研究

期刊:Hemasphere
影响因子:14.6
doi:10.1002/hem3.70100
Dovern, Elisabeth; Nijland, Sterre J A M; Braamse, Annemarie M J; van Muilekom, Maud M; Suijk, Elisabeth M J; Hoogendoorn, Gerianne M; van Tuijn, Charlotte F J; DeBaun, Michael R; Biemond, Bart J; Haverman, Lotte; Nur, Erfan
细胞生物学
发育与干细胞
干细胞
发表日期：2025
文献求助 收藏

Patient reported outcomes used in clinical trials and core outcome sets for individuals with genetic intellectual disability: a scoping review

临床试验中使用的患者报告结局和遗传性智力障碍患者的核心结局指标集：范围界定综述

期刊:Journal of Neurodevelopmental Disorders
影响因子:4
doi:10.1186/s11689-025-09633-5
van Silfhout, Nadia Y; van Muilekom, Maud M; van Karnebeek, Clara D; Daams, Joost G; Haverman, Lotte; van Eeghen, Agnies M
发表日期：2025
文献求助 收藏

Developing a core outcome set for Menière's disease trials, the COSMED study: a scoping review on outcomes used in existing trials

为梅尼埃病试验制定核心结局指标集：COSMED 研究：现有试验中使用的结局指标范围界定综述

期刊:Frontiers in Neurology
影响因子:2.8
doi:10.3389/fneur.2025.1516350
Boreel, Maud M E; van Esch, Babette F; van Beers, Maartje A; Kaski, Diego; Bruintjes, Tjasse D; van Benthem, Peter Paul G
发表日期：2025
文献求助 收藏

Pharmacological Treatment of Neuropsychiatric Symptoms in Huntington's Disease: A Systematic Review

亨廷顿病神经精神症状的药物治疗：系统评价

期刊:Movement Disorders Clinical Practice
影响因子:2.7
doi:10.1002/mdc3.14343
Andriessen, Ruben L; Oosterloo, Mayke; Molema, Jory; Daemen, Maud M J; Linden, David E J; Leentjens, Albert F G
发表日期：2025
文献求助 收藏

Navigating Life With Parkinson's Disease: A Focus Group Study on Coping Strategies and Considerations for Self-Management Support

帕金森病患者如何应对生活：一项关于应对策略和自我管理支持考量的焦点小组研究

期刊:
影响因子:
doi:10.1111/jan.16414
Daemen, Maud M J; De Bruijn-Heijligers, Bouke A A G; Van Der Heijden, Colin; Boots, Lizzy M M; Oosterloo, Mayke; De Vugt, Marjolein E; Duits, Annelien A
帕金森
神经科学
发表日期：2025
文献求助 收藏

Patient reported outcomes that matter to individuals with (genetic) intellectual disabilities: a qualitative study

患者报告的对（遗传性）智力障碍患者重要的结局：一项定性研究

期刊:Journal of Neurodevelopmental Disorders
影响因子:
doi:10.1186/s11689-025-09647-z
van Silfhout, Nadia Y; van Muilekom, Maud M; van Karnebeek, Clara D; Haverman, Lotte; van Eeghen, Agnies M
发表日期：2025
文献求助 收藏

Amygdalar and hippocampal volume loss in limbic-predominant age-related TDP-43 encephalopathy

边缘系统为主的年龄相关性TDP-43脑病中的杏仁核和海马体积减少

期刊:Brain
影响因子:
doi:10.1093/brain/awaf201
Wesseling, Alex; Calandri, Ismael L; Bouwman, Maud M A; Reijner, Niels; Deshayes, Natasja A C; Barkhof, Frederik; Ossenkoppele, Rik; van de Berg, Wilma D J; Rozemuller, Annemieke J M; Pijnenburg, Yolande A L; Hoozemans, Jeroen J M; Jonkman, Laura E
神经科学
发表日期：2025
文献求助 收藏

Hippocampal subfields: volume, neuropathological vulnerability and cognitive decline in Alzheimer's and Parkinson's disease

海马亚区：体积、神经病理学脆弱性和阿尔茨海默病和帕金森病中的认知衰退

期刊:Alzheimers Research & Therapy
影响因子:
doi:10.1186/s13195-025-01768-w
Bouwman, Maud M A; Frigerio, Irene; Lin, Chen-Pei; Reijner, Niels; van de Berg, Wilma D J; Jonkman, Laura E
阿尔茨海默症
Hippo
帕金森
神经科学
发表日期：2025
文献求助 收藏